Department of Family Medicine and Public Health, University of California, San Diego, La Jolla, California.
NAFLD Research Center, Department of Medicine, University of California, San Diego, La Jolla, California; Université Lyon 1, Hospices Civils de Lyon, Lyon, France.
Clin Gastroenterol Hepatol. 2020 Mar;18(3):741-743. doi: 10.1016/j.cgh.2019.03.045. Epub 2019 Apr 4.
Nonalcoholic fatty liver disease (NAFLD) is currently the most common chronic liver disease in developed countries. Patients with nonalcoholic steatohepatitis (NASH) are considered to be at a higher risk of fibrosis progression and development to cirrhosis and hepatocellular carcinoma.
非酒精性脂肪性肝病(NAFLD)是目前发达国家最常见的慢性肝病。患有非酒精性脂肪性肝炎(NASH)的患者被认为纤维化进展和发展为肝硬化和肝细胞癌的风险更高。